newsfilter
← Latest News
Business Wire·

Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day

Company to discuss long-range financial outlook and strategic roadmap for rapid and sustainable growth Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving